Flash FinanceUS
After hours S&P 5007,549.94+2.35% Nasdaq25,253.14+2.74% Dow 3052,389.75+2.15% Russell 20002,840.81+3.15% Nasdaq-10027,907.62+3.40% MidCap 4003,715.23+3.13% SmallCap 6001,722.37+2.89% VIX19.92-22.31% 10Y Yield4.86+0.10% Close of Nov 09, 2026
AI brief of an SEC Form 8-K · Labcorp (LH)

Labcorp: EVP Mark Schroeder to retire effective April 1, 2026

Neutral Impact 3 of 5 leadership Written later

Labcorp said Mark Schroeder, Executive Vice President and President of Diagnostics Laboratories and Chief Operations Officer, notified the company on December 9, 2025, of his intention to retire. His retirement takes effect April 1, 2026, giving the company about three months to plan for the departure of a senior operating executive.

Key points

  • Mark Schroeder notified Labcorp of his retirement on December 9, 2025.
  • Retirement is effective April 1, 2026.
  • Schroeder held the roles of EVP and President, Diagnostics Laboratories, and Chief Operations Officer.
  • The filing does not name a successor or describe any compensation arrangements.

The filing

CompanyLabcorp (LH)
Form8-K, current report
Filed with the SECDec 15, 2025, 4:03 PM ET
Accession number0000920148-25-000123

Items reported: 5.02 Director / Officer Change

Read the filing on SEC.gov ↗

Written by AI on Nov 8, 2026, 1:10 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on December 15, 2025.

Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.